| Bioactivity | CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1]. |
| Name | CGP-35949 sodium |
| CAS | 111130-13-3 |
| Formula | C23H25ClN5NaO5 |
| Molar Mass | 509.92 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Beck A, et al. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4. |
CGP-35949 sodium
CAS: 111130-13-3 F: C23H25ClN5NaO5 W: 509.92
CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.